Summary
Assistant Professor, Department of Neurology at Emory University
Secondary appointment, Department of Psychiatry
Program Director, Emory’s Neuroethics Program
Dr. Rommelfanger’s current research explores the nature and utility of placebo using Psychogenic Movement Disorders as a therapeutic model. She is also the Neuroscience Editor-in-Residence for the American Journal of Bioethics Neuroscience.
OnAir Post: Karen Rommelfanger, PhD – Emory
